Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction
Stopped early · Phase 4
Conditions studied: Depression
In brief
Sexual dysfunction is a common side effect of selective serotonin reuptake inhibitors (SSRIs). The hypotheses of this study are that:1. subjects with major depression or dysthymia who are being treated with an SSRI and experiencing treatment-related sexual dysfunction will experience less sexual dysfunction if they are switched to duloxetine, and 2. they will experience either improved antidepressant response or no loss of antidepressant response.
Key facts
- Study ID
- NCT00398632
- Run by
- Stanford University
- People needed
- 6
- Starts
- 2006-11-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2017-11-17
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.